Cornelius Vanderbilt (@BlueFishCap) header
Cornelius Vanderbilt (@BlueFishCap) profile picture

Trading ideas and forecasts on stocks. My posts aren't investment advice, do your own DD. 📈 Sharing: Stock picks 🏦 Market trends 🌍 Portfolio updates 🔄

Amsterdam, The Netherlands
Joined April 2014
Photo by Cornelius Vanderbilt (@BlueFishCap)Photo by Cornelius Vanderbilt (@BlueFishCap)Photo by Cornelius Vanderbilt (@BlueFishCap)Photo by Cornelius Vanderbilt (@BlueFishCap)Photo by Cornelius Vanderbilt (@BlueFishCap)Photo by Cornelius Vanderbilt (@BlueFishCap)Photo by Cornelius Vanderbilt (@BlueFishCap)Photo by Cornelius Vanderbilt (@BlueFishCap)Photo by Cornelius Vanderbilt (@BlueFishCap)Photo by Cornelius Vanderbilt (@BlueFishCap)
Ugly end to October. Today: Nasdaq-100 -3.5%, chips -7.2%. Intel's weak outlook hit the group: $AMD -11%, Nvidia -4%. October: chips -15%, Nasdaq-100 -6.7%. Energy +14%, staples +11%, utilities +10%. Cash flow beat AI promises. #StockMarket #Nasdaq #Semiconductors
1
1
71
Setup: $ABBV (AbbVie) Chips -8%, Nasdaq-100 -3.5%. AbbVie: 52-week high, ~296. Why: Q3 beat, outlook, dividend raised. New drugs Skyrizi +23%, Rinvoq +24% outweigh Humira's -31%. Trigger: 291.40 (cleared) Wrong if: below 271 Earnings: out today #Stocks #StockMarket #Pharma
39
$INTC -29% today, to ~65. On pace for its worst day since 1974. The quarter beat. The outlook didn't: Q4 sales ~9% under forecasts. Why: AI servers grab memory chips, prices soared, PC makers cut orders. Intel's PC sales: -20%+ vs Q3. #StockMarket #Semiconductors #AI
44
S&P 500: -0.3%. The average stock: +1.2%. Why: Alphabet -12.6% on a sales miss dragged it. Health care +2.4%, small caps +1%. After the close: $AMZN -7%. Cloud +39%, fastest in 5 years. But sales missed and it burned $42B of cash in 12 months. #StockMarket #SP500 #Earnings
70
Breakout: $ECO (Okeanis, oil tankers) Oil sails the long way around Hormuz. Longer trips need more ships: its fleet earned 3.6x more per day in Q2. New high, ~101.5. +209% in 2026. Trigger: 100.68 (cleared) Wrong if: below 91.62 Earnings: 11 Nov #Stocks #StockMarket #Shipping
126
$LLY +7% today, to a record high (~1,380). Why: sales +39% to $24.4B, $1.8B above forecasts. Mounjaro +65%, Zepbound +49%. 2026 sales outlook raised by $5.5B. Meanwhile the Nasdaq-100 is -1.6%. Today's best growth story isn't a chip stock. #StockMarket #Earnings #Pharma
33
Same AI boom. Opposite verdicts. $MSFT +3.6% after hours: Azure +48%, and a lower 2026 spending forecast. Alphabet -11%: cloud +103%, but it burned $9B of cash and sees "significant" more spending in 2027. Investors pay for AI profits, not AI bills. #StockMarket #Earnings #AI
68
$VRT +14% today, to ~237. Vertiv makes the power and cooling gear inside AI data centers. Q3 sales +61%. Orders more than doubled. Full-year outlook raised. Still 37% under its May high. Sales show today. Orders show next year. #AI #StockMarket #Earnings
40
Setup to watch: $ZBRA (Zebra) Its scanners, rugged phones and machine vision run warehouses, stores and hospitals. EPS guide +33%. 12-week base after a 26% earnings gap. Volume drying up. Trigger: above 392.78 Wrong if: below 365 Earnings: Tue 3 Nov #StockMarket #Stocks
1
128
Why it's on our radar: · Q2 sales +20%, EPS beat by 45%, margin 20.6% vs 14.2% · Free cash flow guide raised to $1B+ · ~18x this year's earnings Why we wait: the last report moved it 26%, and memory chip costs are the swing risk. Let earnings confirm the breakout. #Investing
18
Setup to watch: $OABI (OmniAb) Drugmakers use its engineered animals to find antibodies, then pay milestones + royalties. Eli Lilly just signed on. Up 160% in 3 months, now pressing 5.13. Trigger: above 5.43 Wrong if: below 4.50 Earnings: Fri 30 Oct #StockMarket #Biotech
1
148
Why it's on our radar: · 110+ partners, 34 drugs in trials, ~19 trial readouts due through 2027 · Cash outlook raised to ~$51M · Analysts: 7 Buy, 0 Hold Why we wait: it still loses money, trades thin, and reports Friday. Let earnings pick the direction. #Investing #Stocks
14
Wall Street's big night, in CET: 19:00 Fed decision. Odds of no change: ~91%. 19:30 Fed chief Warsh speaks. Watch for a December hike hint. After 21:00: Microsoft + $GOOGL earnings, $7.9T of stock in one night. Watch AI spending. Set alarms. #StockMarket #Fed #Earnings
37
Same industry, opposite days. S&P 500 +0.6%, Nasdaq-100 +1.3%, chips +3.6%. But water stocks split: $PNR +12.8%, the S&P's best: sales beat, pool slump ending. Xylem -14.2%: cut its outlook as utilities delay orders. The outlook moves the stock. #StockMarket #Earnings #SP500
1
55
$BA -9.6% today, to ~170, an 18-month low. Its Q3 loss shrank. Orders hit a record $745B. So why? The 737 ramp slips to early 2027, and its 2027 cash outlook ($3B) is about half what Wall Street expected. Orders don't pay bills. Deliveries do. #Boeing #StockMarket #Earnings
1
290
$CLS (Celestica) +10% after the open, to ~272. Why: AI data center demand. Sales +83%, and it sees 2027 sales of $40B (+90%). Clients' 2028 plans are higher still. But it's 43% under its high, below its 50-day average. Good news isn't a fixed chart. #AI #StockMarket #Earnings
1
67
The AI trade woke up today. Nasdaq-100 +1.1%, chips +2.8%, S&P 500 +0.7%. Why: Anthropic, maker of the Claude AI models, filed to go public. $MU +3%, AMD +2.8%, Nvidia +2.4%. One filing won't end the AI debate. Big Tech earnings this week will. #StockMarket #AI #Nasdaq
43
Short setup: $COIN (Coinbase) Stocks rose today. Coinbase fell 2.4% to ~160, below its 1-month low, 56% off its high. Why: sales seen -36% y/y, Bitcoin ETFs lost $635M Friday. Trigger: below 163.33 (hit) Wrong if: above 182.93 Earnings: 29 Oct #Stocks #StockMarket #Crypto
62
$TSLA +5.9% after the open, to ~394. Why: Barclays upgraded it, target $450 (from $370). The bet: a SpaceX merger, and a battery business nearly sold out for 2027 on AI data center demand. Worst Mag 7 stock this year. Best in October. #Tesla #StockMarket #Investing
44
Midterms are 9 days away. History says: S&P 500 one year after each midterm since 1950: up 19 of 19 times. Average +15%. The worst: +1%, a year that included the 1987 crash. Why: the uncertainty clears, whoever wins. Not a guarantee. A tailwind. #StockMarket #SP500 #Investing
42